Azithromycin – Full Introduction
Azithromycin is a broad-spectrum macrolide antibiotic widely used to treat bacterial infections. It is valued for its long half-life, tissue penetration, and convenient dosing schedule.
Drug Class
-
Macrolide antibiotic
-
Bacteriostatic (inhibits bacterial growth)
Mechanism of Action
Azithromycin works by binding to the 50S subunit of bacterial ribosomes, which:
-
Inhibits bacterial protein synthesis
-
Prevents bacterial growth and replication
It is effective against a wide range of gram-positive, gram-negative, and atypical bacteria.
Therapeutic Uses
-
Respiratory tract infections (pneumonia, bronchitis, sinusitis)
-
Skin and soft tissue infections
-
Sexually transmitted infections (chlamydia, gonorrhea)
-
Otitis media (middle ear infection)
-
Pertussis (whooping cough)
-
Mycobacterial infections in combination therapy
Benefits
-
Long half-life → once-daily dosing
-
Good tissue penetration
-
Generally well tolerated
-
Effective against atypical organisms (Mycoplasma, Chlamydia)
-
Shorter treatment courses (3–5 days in many infections)
Common Side Effects
-
Nausea and vomiting
-
Diarrhea
-
Abdominal pain
-
Mild headache
Serious but Rare Side Effects
-
Allergic reactions (rash, anaphylaxis)
-
Hepatotoxicity (rare)
-
QT interval prolongation → risk of arrhythmias
-
Severe diarrhea due to Clostridium difficile infection (rare)
Contraindications & Precautions
-
Known hypersensitivity to azithromycin, erythromycin, or other macrolides
-
History of QT prolongation or cardiac arrhythmias
-
Severe hepatic impairment
-
Use caution in patients taking other QT-prolonging drugs
Dosage & Administration
-
Adults: 500 mg on day 1, then 250 mg once daily for 4 more days (common regimen)
-
Children: Dose based on body weight (10 mg/kg on day 1, then 5 mg/kg once daily for 4 days)
-
Available forms: tablet, suspension/syrup, IV
-
Can be taken with or without food
Conclusion
Azithromycin is a safe and effective antibiotic for a wide range of infections, offering the advantages of once-daily dosing and short treatment courses. Monitoring is advised in patients with cardiac or hepatic risks.
.webp)
0 Comments